Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryutaro Asano

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|October 20, 2007
Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528Koki Makabe, Takeshi Nakanishi, Kouhei Tsumoto, et al.
Biosensors & Bioelectronics|March 29, 2024
The 2.5<sup>th</sup> generation enzymatic sensors based on the construction of quasi-direct electron transfer type NAD(P)-Dependent dehydrogenasesKurea Ikegai, Junko Okuda-Shimazaki, Truc Thanh Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagentRyutaro Asano, Yukiko Sone, Koki Makabe, et al.
Biosensors & Bioelectronics|January 23, 2026
Strategic aptamer evolution for SARS-CoV-2 to enable the detection in human salivaDaimei Miura, Wakana Hayashi, Sakura Nashiki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
International Journal of Molecular Sciences|March 14, 2026
A Unique Insertion Loop Facilitates Tight NAD<sup>+</sup> Binding in Nicotinoprotein: Insights from In Vitro Loop Engineering and In Silico StudiesHoucheng Xue, Takumi Yanase, Junko Okuda-Shimazaki, et al.
Oncotarget|March 24, 2018
Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinityRyutaro Asano, Keisuke Nagai, Koki Makabe, et al.
International Journal of Oncology|April 8, 2010
Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coliAdel Badran, Ryutaro Asano, Makoto Nakayama, et al.
Anticancer Research|May 17, 2002
T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibodyAruto Ueno, Fumiko Arakawa, Hironori Abe, et al.
Biochemical and Biophysical Research Communications|November 28, 2007
Grafting of material-binding function into antibodies Functionalization by peptide graftingTakamitsu Hattori, Mitsuo Umetsu, Takeshi Nakanishi, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|October 20, 2007
Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528Koki Makabe, Takeshi Nakanishi, Kouhei Tsumoto, et al.
Biosensors & Bioelectronics|March 29, 2024
The 2.5<sup>th</sup> generation enzymatic sensors based on the construction of quasi-direct electron transfer type NAD(P)-Dependent dehydrogenasesKurea Ikegai, Junko Okuda-Shimazaki, Truc Thanh Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagentRyutaro Asano, Yukiko Sone, Koki Makabe, et al.
Biosensors & Bioelectronics|January 23, 2026
Strategic aptamer evolution for SARS-CoV-2 to enable the detection in human salivaDaimei Miura, Wakana Hayashi, Sakura Nashiki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
International Journal of Molecular Sciences|March 14, 2026
A Unique Insertion Loop Facilitates Tight NAD<sup>+</sup> Binding in Nicotinoprotein: Insights from In Vitro Loop Engineering and In Silico StudiesHoucheng Xue, Takumi Yanase, Junko Okuda-Shimazaki, et al.
Oncotarget|March 24, 2018
Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinityRyutaro Asano, Keisuke Nagai, Koki Makabe, et al.
International Journal of Oncology|April 8, 2010
Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coliAdel Badran, Ryutaro Asano, Makoto Nakayama, et al.
Anticancer Research|May 17, 2002
T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibodyAruto Ueno, Fumiko Arakawa, Hironori Abe, et al.
Biochemical and Biophysical Research Communications|November 28, 2007
Grafting of material-binding function into antibodies Functionalization by peptide graftingTakamitsu Hattori, Mitsuo Umetsu, Takeshi Nakanishi, et al.
Pageof 12